ERJ
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Published online before print December 19, 2007, 10.1183/09031936.00058907
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplementary data
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (1)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Reuter, S.
Right arrow Articles by Taube, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Reuter, S.
Right arrow Articles by Taube, C.
Eur Respir J 2008; 31:773-782
Copyright ©ERS Journals Ltd 2008

Mast cell-derived tumour necrosis factor is essential for allergic airway disease

S. Reuter1, A. Heinz1, M. Sieren1, R. Wiewrodt1, E. W. Gelfand2, M. Stassen3, R. Buhl1 and C. Taube1,2

1 III. Medical Clinic, Dept of Pulmonary Medicine, and 3 Institute for Immunology, University of Mainz, Mainz, Germany. 2 Division of Cell Biology, Dept of Paediatrics, National Jewish Medical and Research Center, Denver, CO, USA.

CORRESPONDENCE: C. Taube, III. Medical Clinic, Dept of Pulmonary Medicine, Johannes Gutenberg University, Langenbeckstr. 1, 55101 Mainz, Germany. Fax: 49 6131176668. E-mail: taube{at}3-med.klinik.uni-mainz.de

Keywords: Asthma, immunology, mast cell, tumour necrosis factor

Received: May 15, 2007
Accepted December 12, 2007

Mast cells are thought to contribute to allergic airway disease. However, the role of mast cell-produced mediators, such as tumour necrosis factor (TNF), for the development of allergic airway disease is unclear.

In order to define the role of mast cells in acute allergic airway disease two strains of mast cell-deficient mice (KitW/Wv and KitW-sh/W-sh) were studied.

Compared with their wild-type littermates, KitW/Wv and KitW-sh/W-sh mice developed significantly lower airway responsiveness to methacholine and less airway inflammation and goblet cell metaplasia, following sensitisation in the absence of adjuvant and airway challenge. Transfer of bone marrow-derived mast cells (BMMCs) from wild-type mice to KitW-sh/W-sh mice reconstituted both airway responsiveness and inflammation to levels similar to those in sensitised and challenged wild-type mice. In contrast, sensitised KitW-sh/W-sh mice reconstituted with BMMCs from TNF-deficient mice were still severely impaired in their ability to develop airway hyperresponsiveness, inflammation or goblet cell metaplasia following allergen challenge.

The present results demonstrate the significance of mast cells in the development of airway disease and highlight the importance of mast cell-derived tumour necrosis factor in these responses.




This article has been cited by other articles:


Home page
J. Immunol.Home page
C. Song, L. Luo, Z. Lei, B. Li, Z. Liang, G. Liu, D. Li, G. Zhang, B. Huang, and Z.-H. Feng
IL-17-Producing Alveolar Macrophages Mediate Allergic Lung Inflammation Related to Asthma
J. Immunol., November 1, 2008; 181(9): 6117 - 6124.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2008 by the European Respiratory Society.